HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Øyvind Halskau Selected Research

Paclitaxel (Taxol)

11/2018A biophysical study on the mechanism of interactions of DOX or PTX with α-lactalbumin as a delivery carrier.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Øyvind Halskau Research Topics

Disease

3Neoplasms (Cancer)
11/2018 - 02/2010
2Parkinson Disease (Parkinson's Disease)
01/2021 - 12/2019
1Neuroblastoma
12/2019
1Neurodegenerative Diseases (Neurodegenerative Disease)
12/2019

Drug/Important Bio-Agent (IBA)

2SynucleinsIBA
01/2021 - 12/2019
2LipidsIBA
01/2021 - 12/2019
2Lactalbumin (alpha-Lactalbumin)IBA
09/2015 - 02/2010
1CholesterolIBA
01/2021
1Biological ProductsIBA
12/2019
1Paclitaxel (Taxol)FDA LinkGeneric
11/2018
1Doxorubicin (Adriamycin)FDA LinkGeneric
11/2018
1Oleic AcidsIBA
09/2015
1Phospholipids (Phosphatides)FDA LinkGeneric
02/2010
1Oleic Acid (Oleate)IBA
02/2010

Therapy/Procedure

1Therapeutics
11/2018